🔎 Trials Near Me

Home › Brain Tumors › Minnesota

Brain Tumors clinical trials in Minnesota

18 studies for Brain Tumors are looking for participants at sites in Minnesota.

Cities in Minnesota

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

  • Mayo Clinic Health System in Albert Lea, Albert Lea
  • Mayo Clinic Health Systems-Mankato, Mankato
  • Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05222620

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

  • Mayo Clinic Minnesota, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05733312

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

  • University of Minnesota Radiation Oncology, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07831772

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Masonic Cancer Center University of Minnesota, Minneapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0129, Rochester
  • Local Institution - 0174, Rochester
  • Local Institution - 0181, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Minnesota Oncology - Burnsville, Burnsville
  • Cambridge Medical Center, Cambridge
  • Mercy Hospital, Coon Rapids
  • and 21 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04511013

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • Children's Hospital and Clinics of Minnesota, Minneapolis
RecruitingPhase 2
59 Months · All sexes · Updated Sep 15, 2026 · NCT05535166

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

  • Mayo Clinic in Rochester, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03750227

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

  • Mayo Clinic in Rochester, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT04047264

Ommaya Reservoir Placement for Brain Tumor Biomarker Access

  • Mayo Clinic in Rochester, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT04692337

Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors

  • Mayo Clinic in Rochester, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06322602

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • Abbott Northwestern Hospital, Minneapolis
  • University of Minnesota, Minneapolis
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

  • University of Minnesota, Minneapolis
Recruiting
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

  • Mayo Clinic in Rochester, Rochester
RecruitingHealthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Jun 10, 2026 · NCT06788886

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

  • Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06667726

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Mayo Clinic Cancer Center, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Allina Health Cancer Institute, Minneapolis
  • Mayo Clinic, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Mercy Hospital, Coon Rapids
  • Minnesota Oncology Hematology PA-Maplewood, Maplewood
  • Abbott-Northwestern Hospital, Minneapolis
  • and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.